UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
78.59 -1.21 (-1.52%) GOLD FUTURES
2,424.60 -13.90 (-0.57%) DOW
39,830.96 +24.19 (+0.06%) Bitcoin GBP
55,204.33 +2,071.16 (+3.90%)
Citius Pharmaceuticals, Inc. (CTXR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 12:21PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 119.21M |
| Enterprise value | 107.02M |
| Trailing P/E | N/A |
| Forward P/E | 1.29 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.50 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.54 |
| 52-week change 3 | -40.00% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 1.4000 |
| 52-week low 3 | 0.6000 |
| 50-day moving average 3 | 0.7682 |
| 200-day moving average 3 | 0.7685 |
Share statistics
| Avg vol (3-month) 3 | 983.83k |
| Avg vol (10-day) 3 | 1.27M |
| Shares outstanding 5 | 180.67M |
| Implied shares outstanding 6 | 180.67M |
| Float 8 | 168.36M |
| % held by insiders 1 | 6.81% |
| % held by institutions 1 | 15.09% |
| Shares short (30 Apr 2024) 4 | 14.43M |
| Short ratio (30 Apr 2024) 4 | 10.99 |
| Short % of float (30 Apr 2024) 4 | 8.58% |
| Short % of shares outstanding (30 Apr 2024) 4 | 7.99% |
| Shares short (prior month 28 Mar 2024) 4 | 12.43M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 09 Jun 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 09 Jun 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -25.08% |
| Return on equity (ttm) | -42.15% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -39.11M |
| Net income avi to common (ttm) | -37.35M |
| Diluted EPS (ttm) | -0.2300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 12.56M |
| Total cash per share (mrq) | 0.07 |
| Total debt (mrq) | 374.83k |
| Total debt/equity (mrq) | 0.47% |
| Current ratio (mrq) | 5.17 |
| Book value per share (mrq) | 0.50 |
Cash flow statement
| Operating cash flow (ttm) | -30.3M |
| Levered free cash flow (ttm) | -18.92M |
© 2024 Yahoo. All rights reserved.